Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
101 (47%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RISEDRONATE | 5MG | TABLET | Resolved | 2022-06-30 | 2022-12-08 | 163948 |
| TEVA-RISEDRONATE | 150MG | TABLET | Resolved | 2022-06-30 | 2024-02-06 | 163957 |
| TEVA-RISEDRONATE | 30MG | TABLET | Resolved | 2024-01-18 | 2025-04-29 | 216497 |
| TEVA-RISPERIDONE | 0.5MG | TABLET | Resolved | 2017-03-13 | 2023-10-03 | 1566 |
| TEVA-RISPERIDONE | 1.0MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42601 |
| TEVA-RISPERIDONE | 0.25MG | TABLET | Resolved | 2022-06-16 | 2022-09-08 | 162861 |
| TEVA-RISPERIDONE | 3.0MG | TABLET | Resolved | 2022-09-07 | 2022-12-22 | 168744 |
| TEVA-RISPERIDONE | 1.0MG | TABLET | Resolved | 2022-09-22 | 2022-12-22 | 170004 |
| TEVA-RISPERIDONE | 4MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176782 |
| TEVA-RISPERIDONE | 3.0MG | TABLET | Resolved | 2020-03-06 | 2020-04-02 | 107978 |
| TEVA-RISPERIDONE | 4.0MG | TABLET | Resolved | 2020-03-06 | 2020-04-02 | 107981 |
| TEVA-RISPERIDONE | 0.25MG | TABLET | Resolved | 2020-06-04 | 2020-07-09 | 116672 |
| TEVA-RISPERIDONE | 3.0MG | TABLET | Resolved | 2021-05-20 | 2021-06-03 | 139743 |
| TEVA-RISPERIDONE | 4.0MG | TABLET | Resolved | 2021-05-20 | 2021-07-09 | 139746 |
| TEVA-RISPERIDONE | 0.25MG | TABLET | Resolved | 2021-05-20 | 2021-07-22 | 139749 |
| TEVA-RIVAROXABAN | 15MG | TABLET | Resolved | 2024-02-15 | 2024-07-03 | 219671 |
| TEVA-RIVAROXABAN | 20MG | TABLET | Resolved | 2024-05-09 | 2024-06-17 | 227456 |
| TEVA-RIVAROXABAN | 20MG | TABLET | Resolved | 2024-06-27 | 2025-01-09 | 231436 |
| TEVA-RIVAROXABAN | 10MG | TABLET | Resolved | 2025-03-06 | 2025-03-07 | 252087 |
| TEVA-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-10 | 2017-09-19 | 9805 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PIOGLITAZONE | 15MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65026 |
| TEVA-PIOGLITAZONE | 30MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65030 |
| TEVA-PIOGLITAZONE | 45MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65033 |
| TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253171 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253174 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253177 |
| TEVA-PREDNISONE | 5MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81376 |
| TEVA-PREGABALIN | 75MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120033 |
| TEVA-PROCTOSONE | 1% 1% 0.5% 0.5% | OINTMENT | Discontinued | 2025-04-25 | 2025-04-25 | 255840 |
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65036 |
| TEVA-QUETIAPINE | 200MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65039 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65044 |
| TEVA-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65047 |
| TEVA-QUININE | 300MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104294 |
| TEVA-QUININE | 200MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125976 |
| TEVA-RABEPRAZOLE EC | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-07-10 | 2020-07-10 | 120015 |
| TEVA-RABEPRAZOLE EC | 10MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-07-10 | 2020-07-10 | 120018 |